Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.

N H Agha, A M Al-Hilli, H A Hassen

    Nuklearmedizin. Nuclear Medicine
    |December 1, 1981
    PubMed
    Summary

    A new method for preparing technetium-99m copper etidronate (99mTc-Cu-EHDP) offers high labeling yields and stability. This agent demonstrates excellent bone uptake and rapid clearance, making it a promising radiopharmaceutical for bone imaging.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDA.

    Nuklearmedizin. Nuclear medicine·1986
    Same author

    Preparation and biokinetic studies of 99mTc-p-butyl-IDA for hepatobiliary scintigraphy.

    Nuklearmedizin. Nuclear medicine·1985
    Same author

    Application of sodium stannite in the preparation of instant [99mTc]HIDA kit.

    The International journal of applied radiation and isotopes·1984
    Same author

    Instant 99mTc-labelled glucoheptonate kit for kidney imaging.

    Nuklearmedizin. Nuclear medicine·1983
    Same author

    Ytterbium-169-phytate: a potential new radiopharmaceutical for functional scintigraphy of the liver.

    The International journal of applied radiation and isotopes·1982
    Same author

    A new technetium-99m-EDTA complex production technique for renal studies.

    The International journal of applied radiation and isotopes·1979

    Area of Science:

    • Nuclear Medicine
    • Radiopharmaceutical Chemistry
    • Biomedical Imaging

    Background:

    • Technetium-99m (99mTc) labeled diphosphonates are crucial for bone scintigraphy.
    • Optimizing labeling methods and understanding radiopharmaceutical behavior are key for diagnostic efficacy.

    Purpose of the Study:

    • To develop and characterize a novel preparation method for 99mTc-Cu-EHDP.
    • To evaluate the stability, biokinetics, and suitability of 99mTc-Cu-EHDP as a bone imaging agent.

    Main Methods:

    • Preparation of 99mTc-Cu-EHDP using instantly formed cuprous ions.
    • Gel chromatography column scanning for fraction analysis.
    • pH influence studies on labeling yield.
    • Biokinetic studies in rabbits and mice, including plasma protein binding assessment in rats.

    Related Experiment Videos

  • Radionuclide imaging in rabbits using a gamma camera.

    • Main Results:

    • High labeling yield achieved for 99mTc-Cu-EHDP at pH 1.6-1.7.
    • Rapid complex formation and stability for at least 4 hours.
    • Demonstrated high bone uptake and fast skeletal elimination in animal models.
    • Comparable plasma protein binding to 99mTc-Sn-EHDP.
    • Successful bone imaging in rabbits, indicating good diagnostic potential.

    Conclusions:

    • The novel preparation method yields a stable and effective 99mTc-Cu-EHDP radiopharmaceutical.
    • 99mTc-Cu-EHDP exhibits favorable biokinetic properties for bone imaging applications.
    • This agent shows promise as a superior alternative for skeletal scintigraphy.